Breye Therapeutics ApS — CVR 40279865
Is this your company?
Verify ownership and add your website, description, services, products, logo, socials and more.
Claim & enrichReviews
Loading…
Verified reviews from Søge users
Company relationship network
Building the network…
Node colour = company status · blue dot = person. Edge colour = how they are linked: ownership, management, founder, or a shared phone / e-mail / website. Toggle any relation type off with the filters. Double-click a company to open it.
Active
Founded 2019
CVR
40279865
↗ Datacvr
Status
Active
Company form
Private limited (ApS)
Start date
2019-02-13
Addresses
Agern Alle 24, 2970 Hørsholm
(RUDERSDAL)
Alternate names
Visus Therapeutics ApS, Ciana Therapeutics ApS
Advertising protected
Yes
Industry (2)
Fremstilling af farmaceutiske præparater
212000
Fremstilling af farmaceutiske præparater
212000
Addresses (2)
Ved Hegnet 2,
2960 Rungsted Kyst
(HØRSHOLM)
2019-02-13
Agern Alle 24,
2970 Hørsholm
(RUDERSDAL)
2023-03-22
Relations (15)
Jørgen Søberg Petersen
Board member
Profile
Ulrik Mouritzen
ADM. DIR.Board member
Profile
Jimmy Arnold V Van Heusden
Chairman
Profile
KR 483 A/S
Auditor
Profile
Visus Holding ApS
FoundersLegal owner
Profile
Ownership: 90%
· Voting: 90%
BII Holdings A/S
Legal owner
Profile
Ownership: 10%
· Voting: 10%
BioInnovation Institute Fonden
Legal owner
Profile
Ownership: 10%
· Voting: 10%
Bradford A. Young
Legal owner
Profile
Ownership: 5%
· Voting: 5%
Chiara Rossana Maria Liberati
Board member
Profile
Carl Johan Kördel
Board member
Profile
Sound Bioventures Fund I AB
Legal owner
Profile
Ownership: 5%
· Voting: 5%
Gabriela Burian
Board member
Profile
Golgi NueroSciences S.R.L.
Legal owner
Profile
Ownership: 5%
· Voting: 5%
Name history (3)
Visus Therapeutics ApS
2019-02-13 — 2020-08-24
Ciana Therapeutics ApS
2020-08-25 — 2022-11-03
Breye Therapeutics ApS
2022-11-04
Lifecycle (1)
2019-02-13 — now
Employees per month
| Period | Employees | FTE (man-years) |
|---|---|---|
| 2026-06 | 4 | 3 |
| 2026-05 | 3 | 2 |
| 2026-04 | 3 | 2 |
| 2026-03 | 4 | 3 |
| 2026-02 | 3 | 2 |
| 2026-01 | 3 | 2 |
| 2025-12 | 5 | 4 |
| 2025-11 | 3 | 2 |
| 2025-10 | 3 | 2 |
| 2025-09 | 4 | 3 |
| 2025-08 | 2 | 2 |
| 2025-07 | 3 | 2 |
| 2025-06 | 4 | 3 |
| 2025-05 | 3 | 2 |
| 2025-04 | 4 | 2 |
| 2025-03 | 4 | 3 |
| 2025-02 | 4 | 2 |
| 2025-01 | 4 | 2 |
| 2024-12 | 6 | 4 |
| 2024-11 | 3 | 2 |
| 2024-10 | 4 | 2 |
| 2024-09 | 6 | 3 |
| 2024-08 | 3 | 2 |
| 2024-07 | 5 | 3 |
| 2024-06 | 5 | 2 |
| 2024-05 | 5 | 2 |
| 2024-04 | 5 | 3 |
| 2024-03 | 5 | 2 |
| 2024-02 | 6 | 3 |
| 2024-01 | 4 | 2 |
| 2023-12 | 3 | 3 |
| 2023-11 | 1 | 1 |
| 2023-10 | 1 | 1 |
| 2023-09 | 3 | 2 |
| 2023-08 | 2 | 1.13 |
| 2023-07 | 1 | 1 |
| 2023-06 | 2 | 2 |
| 2023-05 | 1 | 1 |
| 2023-04 | 1 | 1 |
| 2023-03 | 1 | 1 |
| 2023-02 | 1 | 1 |
| 2023-01 | 1 | 1 |
| 2022-12 | 2 | 2 |
| 2022-11 | 1 | 1 |
| 2022-10 | 1 | 1 |
| 2022-09 | 1 | 1 |
| 2022-08 | 1 | 1 |
| 2022-07 | 1 | 1 |
| 2022-06 | 1 | 1 |
| 2022-05 | 1 | 1 |
| 2022-04 | 1 | 1 |
| 2022-03 | 1 | 1 |
| 2022-02 | 1 | 1 |
| 2022-01 | 1 | 1 |
| 2021-12 | 1 | 1 |
| 2021-11 | 1 | 1 |
| 2021-10 | 1 | 1 |
| 2021-09 | 1 | 1 |
| 2021-08 | 1 | 1 |
| 2021-07 | 1 | 1 |
| 2021-06 | 1 | 1 |
| 2021-05 | 1 | 1 |
| 2021-04 | 1 | 1 |
| 2021-03 | 1 | 1 |
| 2021-02 | 1 | 1 |
| 2021-01 | 1 | 1 |
| 2020-12 | 1 | 1 |
| 2020-11 | 1 | 1 |
| 2020-10 | 1 | 1 |
| 2020-09 | 1 | 1 |
| 2020-08 | 1 | 1 |
| 2020-07 | 1 | 1 |
| 2020-06 | 1 | 1 |
| 2020-05 | 1 | 1 |
Production units (1)
Registration history
2023-03-22
Addresses
2022-11-04
Name history: Breye Therapeutics ApS
2020-08-25
Name history: Ciana Therapeutics ApS
2019-02-13
Addresses
2019-02-13
Name history: Visus Therapeutics ApS
2019-02-13
Company registered
Attributes
Owner registration under 5%
No
Purpose
Selskabets formål er forskning, udvikling og kommercialisering af lægemidler og hermed forbundet virksomhed.
First financial period end
2020-03-31
First financial period start
2019-02-13
Registered capital
50,000 DKK; 53,500 DKK; 125,902 DKK; 133,035 DKK; 261,065 DKK; 325,087 DKK; 341,672 DKK
Share classes
No; No; No; Yes; Yes; Yes; Yes
Capital currency
DKK
Partly paid capital
No
Pseudo CVR number
No
Financial year end
31.03
Financial year start
01.04
Audit opted out
Yes; No
Signing rule
Selskabet tegnes af direktionen.; Selskabet tegnes af bestyrelsesformanden i forening med et bestyrelsesmedlem eller af bestyrelsesformanden i forening med en direktør eller af den samlede bestyrelse
Latest articles date
2019-02-13; 2019-11-05; 2020-08-25; 2020-10-29; 2022-11-04; 2022-11-15; 2023-03-09; 2023-03-22; 2023-06-06; 2023-09-01; 2024-03-01; 2024-05-08; 2024-07-17
Similar companies
Searching...
Didn't find what you need? Try searching
Vehicles